Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at an average $33.93 ($305,385)
  2. 4 Planned sale Director sold 61,200 shares at an average $34.57 ($2,115,673)
  3. 4 Planned sale EVP R&D, Chief Medical Officer sold 5,000 shares at $30.00 ($150,005)
  4. 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $28.00 ($112,000)
  5. 4 Planned sale EVP R&D, Chief Medical Officer sold 3,748 shares at $30.00 ($112,447)
  6. 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $29.30 ($117,200)
  7. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $30.38 ($273,442)
  8. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $31.53 ($283,776)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 895 shares (to pay taxes)
  12. 4 Planned sale SVP, Chief Commercial Officer sold 6,667 shares at an average $31.52 ($210,143)
  13. 4 Shares withheld for taxes Director gave up 793 shares (to pay taxes)
  14. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  15. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  17. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  18. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  19. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
  20. 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)

Page 4 of 67 · 1,323 filings